Diabetes Health » October 2006

October 17, 2006

Over in Prescription Drug Watch, we posted that Merck's new diabetes drug Januvia has been approved by the FDA.

I was struck by one investment analyst's comments about diabetes and all of the new drugs that are being developed to treat it:

Deutsche Bank research analyst Barbara Ryan, in a recent note, called diabetes "hot, hot, hot" with a market size capable of supporting "multiple new blockbuster opportunities."

You don't have diabetes. You have a "blockbuster opportunity"!

FDA approves Merck's diabetes pill

Posted by Staff at 12:43 PM | Comments (3)

October 11, 2006

The National Institutes of Health has begun something called the HEALTHY study, a several-year study following sixth graders and their development of diabetes.

Researchers gave sixth graders at several schools a $50 gift card to Wal Mart in exchange for allowing researchers to draw their blood and track them for two and a half years.

One group of students will be exposed to the kinds of food and gym classes available in most U.S. middle schools, and a second group will get healthier cafeteria food, more rigorous gym classes and advice on healthy behaviors.

Study Seeks Lower Student Diabetes Risk

Posted by Staff at 1:08 PM | Comments (8)

October 2, 2006

A study published in the journal Pediatrics claims that one in 523 Americans under the age of 20 have been diagnosed with Type 2 diabetes.

Type 1, or juvenile, diabetes is the form of the disease most often associated with children, but in recent years, type 2 cases have been found in children. Type 2 is usually diagnosed in older adults and is associated with a combination of genetic predisposition and obesity.

Diabetes is now diagnosed in 1 in 523 young people

Posted by Staff at 5:34 PM | Comments (401)